|



| |
The HERO Board of Directors has approved a five-year, four-phase research
plan.
PHASE ONE defines the impact of the modification of specific single
risk factors and certain risk factor combinations on health care costs; and how
the costs relate to specific diseases. This will determine the reward (reduction
in costs and related specific diseases) when risk factor(s) are eliminated; and
the penalty (unnecessary costs and preventable diseases) when risk factors are
present and maintained. As these data become available through current research,
the impact of the modification of specific risk factor(s) on costs and diseases
will be prioritized. The risk factor(s) which has the greatest impact on costs
and diseases will be number one. The risk factor(s) with the second greatest
impact will be number two, the third number three and so on. This ranking of the
impact of risk factors will be referred to as the HERO scale.
PHASE TWO is a concentrated effort to learn more about behavioral change,
what works, what does not and how to do it most efficiently. The research will
determine the most effective intervention methods and techniques. The objective
is to identify specific intervention activities which result in the greatest
long term behavioral change and permanent risk reduction. This intervention
research will concentrate initially on those specific risk factor(s) which are
proven in Phase One to have the greatest impact in creating unnecessary medical
costs and preventable diseases. Phase Two will develop not only the behavioral
psychology parameters for the most effective interventions, but will also create
specific program approaches which produce the most frequent and consistent, long
term behavioral change.
PHASE THREE deals with creating new attitudes, objectives and practices
relative to health promotion and disease prevention within the practice of
medicine. The objective is to get physicians and para-medical professionals to
understand and accept the HERO generated research data and make health promotion
a routine part of the practice of medicine. One approach is to have HERO health
promotion research published in traditional medical journals, especially those
read by primary care physicians. Another effort is for HERO to establish a
working relationship with several medical schools, and family practice residency
training programs. The intent is to influence the teaching curriculum to include
greater emphasis on health promotion. This will be accomplished by convincing
key thought leaders in the medical profession to become champions for health
promotion and make it a part of the teaching - training experience of future
physicians.
PHASE FOUR is the age of health promotion research specialization.
Currently, most health promotion research is highly generalized. A one size fits
all philosophy prevails. HERO recognizes that there are specific research needs
and opportunities which cannot be generalized. These health promotion research
opportunities are divided into: 1) specific populations, 2) settings, and 3)
delivery modes. Within these research areas the following have initial research
priorities. Specific populations: 1) children, 2) elderly, 3) the indigent, and
4) minorities. Settings to be researched are: 1) the medical profession, 2)
community, 3) schools, and 4) the worksite. In regard to delivery mode, the
following will be researched: 1) person to person, 2) mail, 3) phone, and 4)
internet. The overall objective is to determine the most effective health
promotion protocols for each of the specific populations; when delivered to the
various settings; by the different delivery modes.
|